Quote | Super Quote
Super Quote   |   Detail Quote   |   Interactive Chart   |   Transaction   |   Related News   |   Related Securities   |   Company Information   |   Dividend Records   |   Short Sell
01099 SINOPHARM
RT Nominal up18.400 +0.100 (+0.546%)
Latest  |  Final  |  Interim
Non-current Assets
2024/12 - Final
RMB(K¥)
%Chg
(Compare to Final)
2023/12
RMB(K¥)
2022/12
RMB(K¥)
2021/12
RMB(K¥)
2020/12
RMB(K¥)
Investment Properties393,033-21.623%501,466538,338588,366634,050
Property, plant, equip. & others12,386,202-0.761%12,481,23412,616,76612,424,34212,067,755
Land & other Lease Assets7,246,238-2.295%7,416,4237,030,3986,983,4106,828,091
Intangible Assets8,948,873-12.233%10,196,14910,170,91910,391,72710,729,302
Interests in Asso. & JCEs10,167,8554.707%9,710,7668,987,6518,414,6797,770,772
Other Non-current Assets6,241,472-0.196%6,253,7066,024,6805,687,6565,596,763

45,383,673-2.526%46,559,74445,368,75244,490,18043,626,733
Current Assets
2024/12 - Final
RMB(K¥)
%Chg
(Compare to Final)
2023/12
RMB(K¥)
2022/12
RMB(K¥)
2021/12
RMB(K¥)
2020/12
RMB(K¥)
Inventories62,352,8123.873%60,027,64860,925,83151,499,62547,085,450
Trade Receivables200,260,3048.580%184,435,840169,756,910171,391,518145,338,093
Cash & Bank Balances54,313,359-14.881%63,808,53855,221,62443,529,42850,178,265
Other Current Assets30,521,0966.855%28,563,07433,502,01724,501,57024,988,820
Assets Held for Sale0--00019,345

347,447,5713.151%336,835,100319,406,382290,922,141267,609,973
Current Liabilities
2024/12 - Final
RMB(K¥)
%Chg
(Compare to Final)
2023/12
RMB(K¥)
2022/12
RMB(K¥)
2021/12
RMB(K¥)
2020/12
RMB(K¥)
Trade Payables151,109,2473.053%146,632,453137,085,061128,431,227112,632,393
S-T Debt & Leases64,489,62314.086%56,526,97454,633,19356,699,69656,365,093
Other Current Liabilities34,776,718-9.273%38,331,21043,244,70334,175,62634,979,613
Liab asso w/ Assets Held for Sale0--0000

250,375,5883.679%241,490,637234,962,957219,306,549203,977,099
Net Current Assets97,071,9831.812%95,344,46384,443,42571,615,59263,632,874
Total Assets Less Current Liabilities142,455,6560.389%141,904,207129,812,177116,105,772107,259,607
Non-current Liabilities
2024/12 - Final
RMB(K¥)
%Chg
(Compare to Final)
2023/12
RMB(K¥)
2022/12
RMB(K¥)
2021/12
RMB(K¥)
2020/12
RMB(K¥)
L-T Debt & Leases11,896,511-31.054%17,254,87814,956,99311,668,55012,161,737
Other Non-current Liabilities3,871,843-10.593%4,330,5844,785,9944,783,2875,150,549

15,768,354-26.949%21,585,46219,742,98716,451,83717,312,286
Capital and Reserves
2024/12 - Final
RMB(K¥)
%Chg
(Compare to Final)
2023/12
RMB(K¥)
2022/12
RMB(K¥)
2021/12
RMB(K¥)
2020/12
RMB(K¥)
  Share Capital3,120,6560.000%3,120,6563,120,6563,120,6563,120,656
  Reserves75,763,1396.019%71,461,56164,947,90358,765,35953,238,189
  Others0--0000
Shareholders' Funds78,883,7955.768%74,582,21768,068,55961,886,01556,358,845
Non-controlling Interests47,803,5074.519%45,736,52842,000,63137,767,92033,588,476
Others0--0000

126,687,3025.293%120,318,745110,069,19099,653,93589,947,321
Commitments and Contingent Liabilities
2024/12 - Final
RMB(K¥)
%Chg
(Compare to Final)
2023/12
RMB(K¥)
2022/12
RMB(K¥)
2021/12
RMB(K¥)
2020/12
RMB(K¥)
Commitments----257,311447,396590,396217,198
Contingent Liabilities----0000
Remarks:  Real time quote last updated: 02/04/2025 17:23
  Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service
Security Code
Company Name (Chi/Eng/Keywords)
Industry
Profit / (Loss) Attributable to Shareholders (K¥)RMB 7,049,683
%Change-22.135%
EPS / (LPS)RMB 2.260
NBV Per Share (¥)RMB 25.278
A Member of HKET Holdings
Customer Service Hotline:(852) 2880 7004     Customer Service Email:cs@etnet.com.hk
Copyright 2025 ET Net Limited. http://www.etnet.com.hk ET Net Limited, HKEx Information Services Limited, its Holding Companies and/or any Subsidiaries of such holding companies, and Third Party Information Providers endeavour to ensure the availability, completeness, timeliness, accuracy and reliability of the information provided but do not guarantee its availability, completeness, timeliness, accuracy or reliability and accept no liability (whether in tort or contract or otherwise) any loss or damage arising directly or indirectly from any inaccuracies, interruption, incompleteness, delay, omissions, or any decision made or action taken by you or any third party in reliance upon the information provided. The quotes, charts, commentaries and buy/sell ratings on this website should be used as references only with your own discretion. ET Net Limited is not soliciting any subscriber or site visitor to execute any trade. Any trades executed following the commentaries and buy/sell ratings on this website are taken at your own risk for your own account.